XML 16 R4.htm IDEA: XBRL DOCUMENT v3.6.0.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Dec. 31, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents $ 988 $ 6,946
Trade receivables 7,523 5,350
Inventories 4,954 3,966
Deferred income taxes, see note 1 0 735
Assets Held For Sale 841 0
Prepaid Expenses 1,362 910
Other Current Assets 1,293 491
Total current assets 16,961 18,398
Other non-current assets 1,235 2,341
Deferred Income Taxes 725 250
Property, plant and equipment, net 8,073 6,544
Identifiable intangible assets, net 21,487 7,675
Goodwill 44,409 19,025
Total assets 92,890 54,233
Current liabilities:    
Short-term debt 3,276 1,585
Sales Reserves And Allowances 7,839 6,601
Trade payables 2,157 1,918
Employee Related Obligations 859 710
Accrued Expenses 3,405 1,681
Liabilities Held For Sale 116 0
Other current liabilities 867 510
Total current liabilities 18,519 13,005
Long-term liabilities:    
Deferred income taxes 5,215 1,748
Other taxes and long term liabilities 1,639 1,195
Senior notes and loans 32,524 8,358
Total long term liabilities 39,378 11,301
Total liabilities 57,897 24,306
Teva shareholders' equity:    
Preferred Shares 3,620 3,291
Ordinary shares 54 52
Additional paid-in capital 23,409 17,757
Retained earnings 13,607 14,851
Accumulated other comprehensive loss (3,159) (1,955)
Treasury shares (4,194) (4,227)
Stockholders' equity attributable to Teva shareholders 33,337 29,769
Non-controlling interests 1,656 158
Total equity 34,993 29,927
Total liabilities and equity $ 92,890 $ 54,233